NYSE:NGVT Ingevity - NGVT Stock Forecast, Price & News Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat Daily Premium to add more stocks to your watchlist. Adding Ingevity Co. Please log in to your account or sign up in order to add this asset to your watchlist. $81.76 -0.68 (-0.82%) (As of 02/1/2023 12:28 PM ET) Add Compare Share Share Today's Range$81.42▼$82.7350-Day Range$69.45▼$82.4452-Week Range$56.31▼$82.73Volume33,962 shsAverage Volume162,941 shsMarket Capitalization$3.06 billionP/E Ratio14.07Dividend YieldN/APrice Target$81.50 ProfileAnalyst RatingsChartCompetitorsEarningsFinancialsInsider TradesInstitutional OwnershipHeadlinesOptions ChainSEC FilingsShort InterestSocial Media Ingevity MarketRank™ ForecastAnalyst RatingModerate Buy2.50 Rating ScoreUpside/Downside1.1% Downside$81.50 Price TargetShort InterestBearish1.92% of Float Sold ShortDividend StrengthN/ASustainabilityN/ANews Sentiment0.66Based on 4 Articles This WeekInsider TradingSelling Shares$194,424 Sold Last QuarterProj. Earnings Growth9.28%From $6.36 to $6.95 Per ShareSee Full Details Hide Full Details Overall MarketRank™MarketRank is calculated as an average of available category scores, with extra weight given to analysis and valuation.1.82 out of 5 starsBasic Materials Sector117th out of 161 stocksChemicals & Allied Products Industry11th out of 15 stocks 1.3 Analyst's Opinion Consensus RatingIngevity has received a consensus rating of Buy. The company's average rating score is 2.50, and is based on 1 buy rating, 1 hold rating, and no sell ratings.Price Target Upside/DownsideAccording to analysts' consensus price target of $81.50, Ingevity has a forecasted downside of 1.1% from its current price of $82.39.Amount of Analyst CoverageIngevity has only been the subject of 1 research reports in the past 90 days. Previous Next 2.0 Short Interest Percentage of Shares Shorted1.92% of the float of Ingevity has been sold short.Short Interest Ratio / Days to CoverIngevity has a short interest ratio ("days to cover") of 4.4.Change versus previous monthShort interest in Ingevity has recently increased by 3.19%, indicating that investor sentiment is decreasing. Previous Next 0.0 Dividend Strength Dividend YieldIngevity does not currently pay a dividend.Dividend GrowthIngevity does not have a long track record of dividend growth. Previous Next N/A Sustainability and ESG Overall ESG (Environmental, Social, and Governance) ScoreThere is no current Upright™ data available for NGVT. Previous Next 3.1 News and Social Media Coverage News SentimentIngevity has a news sentiment score of 0.66. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a higher news sentiment than the 0.36 average news sentiment score of Basic Materials companies.News Coverage This WeekMarketBeat has tracked 4 news articles for Ingevity this week, compared to 3 articles on an average week.Search Interest3 people have searched for NGVT on MarketBeat in the last 30 days. Previous Next 2.5 Company Ownership Insider Buying vs. Insider SellingIn the past three months, Ingevity insiders have sold more of their company's stock than they have bought. Specifically, they have bought $0.00 in company stock and sold $194,424.00 in company stock.Percentage Held by InsidersOnly 0.71% of the stock of Ingevity is held by insiders.Percentage Held by Institutions90.01% of the stock of Ingevity is held by institutions. High institutional ownership can be a signal of strong market trust in this company. Previous Next 2.5 Earnings and Valuation Earnings GrowthEarnings for Ingevity are expected to grow by 9.28% in the coming year, from $6.36 to $6.95 per share.Price to Earnings Ratio vs. the MarketThe P/E ratio of Ingevity is 14.18, which means that it is trading at a less expensive P/E ratio than the market average P/E ratio of about 129.25.Price to Earnings Ratio vs. SectorThe P/E ratio of Ingevity is 14.18, which means that it is trading at a less expensive P/E ratio than the Basic Materials sector average P/E ratio of about 90.32.Price to Book Value per Share RatioIngevity has a P/B Ratio of 4.80. P/B Ratios above 3 indicate that a company could be overvalued with respect to its assets and liabilities. Previous Next See Top Rated MarketRank™ Stocks Here About Ingevity (NYSE:NGVT) StockIngevity Corp. engages in the manufacture of specialty chemicals and carbon materials. It operates through the following segments: Performance Chemicals and Performance Materials. The Performance Materials segment consists of automotive technologies and process purifications product families. Automotive technologies produces automotive carbon products used in gasoline vapor emission control systems in cars, trucks, motorcycles and boats. Process purifications produce a number of activated carbon products for food, water, beverage and chemical purification applications. The Performance Chemicals segment primarily addresses applications in three product families: pavement technologies, oilfield technologies, and industrial specialties. The company was founded on March 27, 2015 and is headquartered in North Charleston, SC.Read More Receive NGVT Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Ingevity and its competitors with MarketBeat's FREE daily newsletter. Email Address NGVT Stock News HeadlinesJanuary 27, 2023 | finance.yahoo.comThose who invested in Ingevity (NYSE:NGVT) a year ago are up 24%December 13, 2022 | finance.yahoo.comCan Ingevity Corporation (NYSE:NGVT) Maintain Its Strong Returns?February 1, 2023 | Investing Trends (Ad)Huge Upside Potential With "Staggering" Solar DemandGlobal solar demand is "staggering" right now, according to Bloomberg. Solar installations are set to grow 30% this year alone. And the boom is just beginning, with increasing adoption of solar by commercial, non-profit, and public entities. With only 1% of commercial electricity demand served by on-site solar globally, there is HUGE opportunity for growth.November 20, 2022 | finance.yahoo.comIs Ingevity Corporation (NYSE:NGVT) Potentially Undervalued?November 4, 2022 | finance.yahoo.comHow Much Upside is Left in Ingevity (NGVT)? Wall Street Analysts Think 30%November 2, 2022 | finance.yahoo.comIngevity (NGVT) Q3 Earnings and Revenues Surpass EstimatesNovember 2, 2022 | finance.yahoo.comIngevity reports third quarter 2022 financial resultsOctober 19, 2022 | streetinsider.comIngevity announces dates for third quarter 2022 earnings release and webcast - StreetInsider.comFebruary 1, 2023 | PressReach (Ad)Top AI Tech Stock To WatchToday's stock market news features a Robotics stock with blue sky potential.October 4, 2022 | finance.yahoo.comIngevity completes acquisition of leading pavement marking materials business, Ozark Materials - Yahoo FinanceOctober 3, 2022 | businesswire.comIngevity completes acquisition of leading pavement marking materials business, Ozark Materials - Business WireOctober 3, 2022 | finance.yahoo.comIngevity (NGVT) Wraps Up Expansion of Polyols ProductionSeptember 29, 2022 | businesswire.comIngevity rebrands adsorbed natural gas business to NeuFuel™ and expands carbon- neutral offerings for existing diesel vehicles - Business WireSeptember 29, 2022 | finance.yahoo.comIngevity rebrands adsorbed natural gas business to NeuFuel™ and expands carbon- neutral offerings for existing diesel vehiclesSeptember 29, 2022 | finance.yahoo.comHere's Why Ingevity (NGVT) is a Strong Growth StockSeptember 28, 2022 | finance.yahoo.comIngevity completes planned expansion of caprolactone polyols production to the United States, increases global capacity for polyols by 40% - Yahoo FinanceSeptember 28, 2022 | nz.finance.yahoo.comIngevity completes planned expansion of caprolactone polyols production to the United States, increases global capacity for polyols by 40%September 21, 2022 | businesswire.comIngevity awarded gold rating for corporate social responsibility by EcoVadis, places in the top 3% in its industry - Business WireSeptember 21, 2022 | finance.yahoo.comIngevity awarded gold rating for corporate social responsibility by EcoVadis, places in the top 3% in its industry - Yahoo FinanceSeptember 14, 2022 | nasdaq.comIngevity (NGVT) Gains on Demand Strength and Growth Actions - NasdaqSeptember 14, 2022 | finance.yahoo.comIngevity (NGVT) Gains on Demand Strength and Growth ActionsSeptember 13, 2022 | nasdaq.comWhy Ingevity (NGVT) is a Top Growth Stock for the Long-Term - NasdaqSeptember 13, 2022 | investors.comIngevity Meets 80-Plus Relative Strength Rating Benchmark | Investor's Business Daily - Investor's Business DailySeptember 6, 2022 | nasdaq.comIngevity Breaks Below 200-Day Moving Average - Notable for NGVT - NasdaqSeptember 5, 2022 | nasdaq.comWhy Ingevity Corporation (NYSE:NGVT) Looks Like A Quality Company - NasdaqSeptember 2, 2022 | nasdaq.comHere's Why Ingevity (NGVT) Looks Ripe for Bottom Fishing - NasdaqSeptember 2, 2022 | finance.yahoo.comHere's Why Ingevity (NGVT) Looks Ripe for Bottom FishingSee More Headlines View Price History Chart DataSkip Price History Chart 30 days | 90 days | 365 days | Advanced Chart Receive NGVT Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Ingevity and its competitors with MarketBeat's FREE daily newsletter. Email Address NGVT Company Calendar Last Earnings10/27/2021Today2/01/2023Next Earnings (Estimated)2/22/2023Fiscal Year End12/31/2023Get Stock AlertsIndustry, Sector and Symbol Stock ExchangeNYSE Industry Chemicals & allied products Sub-IndustryN/A SectorBasic Materials Current SymbolNYSE:NGVT Previous SymbolNASDAQ:NGVT CUSIPN/A CIK1653477 Webwww.ingevity.com Phone(843) 740-2300Fax843-740-8165Employees1,850Year FoundedN/APrice Target and Rating Average Stock Price Forecast$81.50 High Stock Price Forecast$87.00 Low Stock Price Forecast$76.00 Forecasted Upside/Downside-0.3%Consensus RatingModerate Buy Rating Score (0-4)2.50 Research Coverage2 Analysts Profitability EPS (Most Recent Fiscal Year)$5.81 Trailing P/E Ratio14.07 Forward P/E Ratio12.86 P/E GrowthN/ANet Income$118.10 million Net Margins13.90% Pretax Margin17.66% Return on Equity36.37% Return on Assets10.01% Debt Debt-to-Equity Ratio1.82 Current Ratio2.22 Quick Ratio1.25 Sales & Book Value Annual Sales$1.39 billion Price / Sales2.20 Cash Flow$8.39 per share Price / Cash Flow9.75 Book Value$17.15 per share Price / Book4.77Miscellaneous Outstanding Shares37,370,000Free Float37,107,000Market Cap$3.06 billion OptionableOptionable Beta1.78 Key ExecutivesJohn C. FortsonPresident, Chief Executive Officer & DirectorMary Dean HallChief Financial Officer & Executive Vice PresidentStuart Edward WoodcockExecutive VP & President-Performance MaterialsErik RippleSenior VP, Chief Growth & Innovation OfficerChristine StunyoChief Human Resources Officer & Senior VPKey CompetitorsInnospecNASDAQ:IOSPBalchemNASDAQ:BCPCPerimeter SolutionsNYSE:PRMLiventNYSE:LTHMHawkinsNASDAQ:HWKNView All CompetitorsInsiders & InstitutionsNew York State Common Retirement FundBought 800 shares on 1/30/2023Ownership: 0.460%Versor Investments LPBought 3,414 shares on 1/30/2023Ownership: 0.009%Rice Hall James & Associates LLCSold 4,436 shares on 1/27/2023Ownership: 0.962%Natixis Advisors L.P.Bought 4,478 shares on 1/27/2023Ownership: 0.087%Strs OhioBought 500 shares on 1/26/2023Ownership: 0.003%View All Insider TransactionsView All Institutional Transactions NGVT Stock - Frequently Asked Questions Should I buy or sell Ingevity stock right now? 2 Wall Street research analysts have issued "buy," "hold," and "sell" ratings for Ingevity in the last year. There are currently 1 hold rating and 1 buy rating for the stock. The consensus among Wall Street research analysts is that investors should "buy" NGVT shares. View NGVT analyst ratings or view top-rated stocks. What is Ingevity's stock price forecast for 2023? 2 equities research analysts have issued 1-year price targets for Ingevity's shares. Their NGVT share price forecasts range from $76.00 to $87.00. On average, they expect the company's stock price to reach $81.50 in the next year. This suggests that the stock has a possible downside of 1.1%. View analysts price targets for NGVT or view top-rated stocks among Wall Street analysts. How have NGVT shares performed in 2023? Ingevity's stock was trading at $70.44 at the beginning of 2023. Since then, NGVT stock has increased by 17.0% and is now trading at $82.39. View the best growth stocks for 2023 here. When is Ingevity's next earnings date? The company is scheduled to release its next quarterly earnings announcement on Wednesday, February 22nd 2023. View our NGVT earnings forecast. How were Ingevity's earnings last quarter? Ingevity Co. (NYSE:NGVT) released its earnings results on Wednesday, October, 27th. The company reported $1.62 earnings per share for the quarter, beating analysts' consensus estimates of $1.54 by $0.08. The company had revenue of $376.80 million for the quarter, compared to analysts' expectations of $354.29 million. Ingevity had a trailing twelve-month return on equity of 36.37% and a net margin of 13.90%. Ingevity's quarterly revenue was up 13.6% on a year-over-year basis. During the same period in the prior year, the business earned $1.79 EPS. What guidance has Ingevity issued on next quarter's earnings? Ingevity updated its FY 2022 earnings guidance on Wednesday, November, 9th. The company provided earnings per share guidance of for the period. The company issued revenue guidance of $1.65 billion-$1.70 billion, compared to the consensus revenue estimate of $1.60 billion. What is John Fortson's approval rating as Ingevity's CEO? 2 employees have rated Ingevity Chief Executive Officer John Fortson on Glassdoor.com. John Fortson has an approval rating of 100% among the company's employees. This puts John Fortson in the top 10% of approval ratings compared to other CEOs of publicly-traded companies. What other stocks do shareholders of Ingevity own? Based on aggregate information from My MarketBeat watchlists, some companies that other Ingevity investors own include Pfizer (PFE), AbbVie (ABBV), General Electric (GE), Verizon Communications (VZ), WestRock (WRK), Abbott Laboratories (ABT), Boeing (BA), Costco Wholesale (COST), Dominion Energy (D) and Johnson & Johnson (JNJ). What is Ingevity's stock symbol? Ingevity trades on the New York Stock Exchange (NYSE) under the ticker symbol "NGVT." Who are Ingevity's major shareholders? Ingevity's stock is owned by a variety of institutional and retail investors. Top institutional shareholders include Rice Hall James & Associates LLC (0.96%), New York State Common Retirement Fund (0.46%), Allspring Global Investments Holdings LLC (0.23%), Gateway Investment Advisers LLC (0.10%), Natixis Advisors L.P. (0.09%) and Peterson Wealth Services (0.07%). Insiders that own company stock include D Michael Wilson, Diane H Gulyas, Erik Spencer Ripple, Frederick J Lynch, John C Fortson, Michael P Smith, Richard Allen White Jr, Richard B Kelson and Stuart Edward Jr Woodcock. View institutional ownership trends. How do I buy shares of Ingevity? Shares of NGVT stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab. Compare Top Brokerages Here. What is Ingevity's stock price today? One share of NGVT stock can currently be purchased for approximately $82.39. How much money does Ingevity make? Ingevity (NYSE:NGVT) has a market capitalization of $3.08 billion and generates $1.39 billion in revenue each year. The company earns $118.10 million in net income (profit) each year or $5.81 on an earnings per share basis. How many employees does Ingevity have? The company employs 1,850 workers across the globe. How can I contact Ingevity? Ingevity's mailing address is 4920 O`Hear Avenue Suite 400, North Charleston SC, 29406. The official website for the company is www.ingevity.com. The company can be reached via phone at (843) 740-2300, via email at daniel.gallagher@ingevity.com, or via fax at 843-740-8165. This page (NYSE:NGVT) was last updated on 2/1/2023 by MarketBeat.com Staff Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Your Password: or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Choose a Password: Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.